Dacomitinib CAS 1110813-31-4

Khoom Piav Qhia

Khoom npe: Dacomitinib CAS TSIS: 1110813-31-4

0010010 nbsp;

0010010 nbsp;

Txhais:

Dacomitinib [USAN];

Dacomitinib (USAN / INN);

(2 E) -N- [4 - [(3-Chloro-4-fluorophenyl) amino] -7-methoxy-6-quinazolinyl] -4- (1-piperidinyl) - 2 - butenamide;

(2 e) -N- {4 - [(3-Chloro-4-Fluorophenyl) amino] -7-Methoxyquinazolin-6-Yl} -4- (Piperidin-1-Yl) tab sis - {{0 }} - Enamide;

(E) -N- [4- (3-chloro-4-fluoroanilino) -7-methoxyquinazolin-6-yl] -4-piperidin-1-ylbut-2-enamide;

0010010 nbsp;

0010010 nbsp;

Tshuaj Txhaum 0010010 amp; Lub cev nqaij daim tawv

Zog: Dawb kom tawv daj daj.

Ntsuas: ≥ 99. 0%

Melting Point: 184-187 ° C

0010010 nbsp;

0010010 nbsp;

Dacomitinib yog Erb-inhibitor, lossis tshuaj tiv thaiv ntawm cov tswvcuab ntawm kev loj hlob ntawm cov kabmob epidermal receptor tsev neeg. Siv los ua tus neeg sawv cev mob qog noj ntshav vim muaj kev soj ntsuam pom tias ntau tshaj li qhov muaj peev xwm nthuav dav cov kab mob hauv yuav luag txhua yam mob uas ua rau neeg mob hlwb ua rau mob taub hau thiab caj dab.

0010010 nbsp;

0010010 nbsp;

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov hu rau peb!

0010010 nbsp;

0010010 nbsp;

Cov khoom hauv qab patent yog muab rau R 0010010 amp; D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

0010010 nbsp;

0010010 nbsp;

Cim npe nrov: dacomitinib cas 1110813-31-4, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: 2 - Butenoic Acid, 4 - (1 - piperidinyl) -, Hydrochloride (1: 1), (2 E) - CAS TSIS TAU: { {4}} 9789 2 - 69-6
• Tom ntej: 2 - [(2, 6-Difluoro-benzyl) -ethoxycarbonyl-amino] -4-dimethylaminomethyl-5- (4-nitro-phenyl) -thiophene-3-carboxylic Acid Ethyl Ester CAS TSIS : 1589503-97-8